TRAX
First Tracks Biotherapeutics Inc
$21.45
-1.82
(-7.82%)
Mkt Cap
701.93M
Volume
315,435
52W Range
14.79-26.8
Sector
Healthcare
Beta
0.00
EPS (TTM)
N/A
P/E Ratio
N/A
Revenue (TTM)
N/A
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
TRAX News
No news available for TRAX.